(MENAFN- GlobeNewsWire - Nasdaq) Portland, OR, Colorado Springs, CO, Houston, TX, Boston, MA, Kansas City, MO, Miami, FL, Phoenix, AZ, Jan. 13, 2023 (GLOBE NEWSWIRE) -- According to Zion Market Research has published a new research report titled “Global Epigenetics Market By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, And Contract Research Organizations), By Product (Reagents, Kits, Instruments, And Enzymes), By Application (Non-Oncology And Oncology), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028” in its research database.
“According to the latest research study, the demand of global epigenetics market size & share in terms of revenue was valued at USD 0.9 billion in 2021 and it is expected to surpass around USD 3.0 billion mark by 2028, growing at a compound annual growth rate (CAGR) of approximately 14.65% during the forecast period 2022 to 2028.”
What are Epigenetics? How big is the Epigenetics Industry?
Epigenetics Report Coverage & Overview:
Epigenetics refers to the study of changes in the heritable phenotype without any alterations in the DNA sequence. The term may also encompass changes made in the genome but does not include any modifications in nucleotide sequence and examples of such mechanisms are histone modification and DNA methylation. The control of gene expression is through the repressor proteins action that is attached to the silencer area of the DNA, these changes may either last through the cell's life even during cell division or may last for multiple generations without impacting the original DNA sequence.
Since epigenetic enzymes can reverse the epigenetic mutation incorporation, they have become a favorite of researchers for cancer treatments. As of 2022, 7 epigenetics drugs have been approved by the U.S. FDA that are used in the treatment of 5 histone inhibitors and 2 methyltransferase inhibitors. The indicators for the approval of epigenetic drugs are hematological malignancies and none of them are for solid tumors, however, research is being conducted for the same. Epigenetic drugs are expected to show the best results when used in combination therapy along with radiation and chemotherapy.
Global pandemic aided the global market growth majorly due to the extensive research conducted worldwide to understand the correlation between the virus and epigenetic mutations. The increased number of medical cases during CO*ID-19 also assisted in the rise in interest of different diagnostic clinics towards epigenetics.
Click Here To Access Free Sample Report of the Global Epigenetics Market @
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package About 250+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on Request Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022 Includes Tables and figures have been updated The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Zion Market Research research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Market Growth Dynamics
The global epigenetics market growth is expected to spur due to the rising number of applications of epigenetics in the treatment of cancer and other disorders. Since epigenetics has proven to be highly efficient in treating certain types of cancer, it is being thoroughly researched by multiple research institutes with the intention to develop necessary drugs and vaccines for disorders that do not have any proper treatments assigned to them. Organizations like the National Cancer Institute, Human Epigenome Consortium, and National Institute of Health have been pushing for higher investment in epigenetics not just for research purposes but for commercialization as well which is expected to aid global market expansion in the coming years.
A lot of key players are now entering into strategic mergers and acquisitions in the epigenetics industry either to increase their global presence or to boost the small-scale manufacturers with their production or innovation thus meeting the globally rising demand along with the addition of newer and more advanced tools that can be used in epigenetics and it may also propel the global market growth.
The standardization concerns related to epigenetics may restrict the global market growth. The adoption of advanced technology is expected to provide global market growth opportunities.
However, a lack of skilled professionals may challenge the global market expansion.
Directly Purchase a copy of the report with TOC @
Report Scope
| Report Attribute | Details |
| Market Size in 2021 | USD 0.9 billion |
| Projected Market Size in 2028 | USD 3.0 billion |
| CAGR Growth Rate | 14.65% CAGR |
| Base Year | 2021 |
| Forecast Years | 2022-2028 |
| Key Market Players | Hologic Inc., Agilent Technologies Inc., Merck Millipore, PerkinElmer Inc., QIAGEN N.V., Illumina Inc., Thermo Fisher Scientific Inc., Abcam Plc., Zymo Research, Active Motif Inc, and others. |
| Key Segment | By Product Type, By Application, By End - Use , and By Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
| Purchase Options | Request customized purchase options to meet your research needs. explore purchase options |
Epigenetics Market: Segmentation Analysis
The global epigenetics market is segmented by end-user, product, application, and region.
By end-user, the global market segments are pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. The global market was dominated by the pharmaceutical & biotechnological companies in 2021 and may follow the same trend during the projection period owing to increased R&D activities in genetics and towards the development of disease-specific treatments coupled with analysis of drug resistance in microorganisms, and molecular studies of cancer and other disorders.
By product, the global market is segmented into reagents, kits, instruments, and enzymes. Reagents like histone & DNA modified are most frequently used whereas PCR, antibodies, and electrophoresis reagents are most commonly utilized epigenetic reagents. PyroMarket Q24 uses pyrosequencing chemistry and is able to deliver the most efficient form of detection in real-time.
By applications, the global market is divided into non-oncology and oncology. In 2021, the highest revenue was generated through applications in the oncology segment because of an increased number of cancer-related cases. Epimutations play a pivot role in cancer etiology and are being heavily researched as of current times.
The global Epigenetics market is segmented as follows:
By end-user:
Pharmaceutical & Biotechnology Companies Academic & Research Institutes Contract Research Organizations
By Product
Reagents Kits Instruments Enzymes
By Application
Browse the full “Global Epigenetics Market By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, And Contract Research Organizations), By Product (Reagents, Kits, Instruments, And Enzymes), By Application (Non-Oncology And Oncology), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028” Report at
Competitive Landscape
Some of the main competitors dominating the global Epigenetics market include -
Hologic Inc. Agilent Technologies Inc. Merck Millipore PerkinElmer Inc. QIAGEN N.V. Illumina Inc. Thermo Fisher Scientific Inc. Abcam Plc. Zymo Research Active Motif Inc
Key Insights from Primary Research :
According to the analysis shared by our research forecaster, the Epigenetics market is likely to expand at a CAGR of around 14.65% during the forecast period (2022-2028). In terms of revenue, the Epigenetics market size was valued at around US$ 0.9 billion in 2021 and is projected to reach US$ 3.0 billion by 2028. Based on type segmentation, the use of reagents was predicted to show maximum market share in the year 2021. Based on application segmentation, Oncology was the leading revenue-generating category in 2021. On the basis of region, North America was the leading revenue generator in 2021.
Have Any Query? Ask Our Experts:
Key questions answered in this report:
What is the market size and growth rate forecast for Epigenetics industry? What are the main driving factors propelling the Epigenetics Market forward? What are the leading companies in the Epigenetics Industry? What segments does the Epigenetics Market cover? How can I receive a free copy of the Epigenetics Market sample report and company profiles?
Key Offerings:
Market Size & Forecast by Revenue | 2022−2028 Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities Market Segmentation – A detailed analysis By Product Type, By Application, By End-Use, and By Region Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Request for Customization on this Report as per your requirements -
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
Regional Analysis :
North America is expected to dominate the global epigenetics market during the forecast period because of the rising number of cancer patients in the region along with the advanced economic state of countries like the USA and Canada where the income capability of the population is relatively higher and they can afford the cost of cancer treatments. The excellent medical reimbursement policies of the governments are expected to encourage the population towards enrolling in cancer treatment which will subsequently aid regional growth.
Asia-Pacific is anticipated to grow significantly as well owing to the regions like India and China witnessing high medical tourism because of the availability of relatively lower costing cancer treatments. The regional growth may also be attributed to the rising strategic collaborations between international organizations and domestic players to expand their consumer databases.
By Region
North America U.S. Canada Rest of North America
Europe France UK Spain Germany Italy Rest of Europe
Asia Pacific China Japan India South Korea Rest of Asia Pacific
The Middle East & Africa Saudi Arabia South Africa Rest of the Middle East & Africa
Latin America Brazil Argentina Rest of Latin America
Recent Developments
In December 2021, Lonza and Agilent Technologies formed a partnership. Lonza is a leading manufacturer of cell and gene therapy. The partnership aims to bring drastic changes in the way customized cell therapies are created and used. In June 2021, Microba Life Sciences and Illumina entered a partnership with the intention to aid researchers with their inventions. The partnership will allow for Microba's extremely high-quality gut microbiome analysis platform and Illumina's NGS tools to be able to create accurate metagenomic data.
To know an additional revised 2022 list of market players, request a brochure of the report:
FREQUENTLY ASKED QUESTIONS
Which key factors will influence epigenetics market growth over 2022-2028? What will be the value of the epigenetics market during 2022-2028? Which region will contribute notably towards the epigenetics market value? Which are the major players leveraging epigenetics growth?
Browse Other Related Research Reports from Zion Market Research:
Fill Finish Manufacturing Market Size and Share:
Viral Vectors and Plasmid DNA Manufacturing Market Size and Share:
Primary Cells Market Size and Share:
Animal Genetics Market Size and Share :
Oligonucleotide Synthesis Market Size and Share:
Protein Engineering Market Size and Share:
Bioburden Testing Market Size and Share:
Genotyping Assay Market Size and Share:
Aseptic Sampling Market Size and Share:
Proteomics Market Size and Share:
About Zion Market Research:
Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client's/customer's conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn:
Follow Us on Twitter:
Follow Us on Facebook:
Follow Us on Pinterest:
Follow Us on YouTube:
Contact Us:
Rushikesh Dorge
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 73877 19999
Web:
Blog:
Still, Looking for More Information? OR Want Data for Inclusion in Magazine, Case Study, or Media?
Email Directly Here with Detail Information:
Tags epigenetics market epigenetics market size epigenetics market share epigenetics market growth epigenetics opportunities zmr pr Related Links fill finish manufacturing market size and share viral vectors and plasmid dna manufacturing market size and share primary cells market size and share animal genetics market size and share oligonucleotide synthesis market size and share protein engineering market size and share bioburden testing market size and share genotyping assay market size and share aseptic sampling market size and share proteomics market size and share epigenetics market epigenetics market size and share subsea pumps market household and diy hand tools market size green energy market healthcare contract development and manufacturing organization market women's digital health market size artificial disc replacement market wound debridement market point of care diagnostics market